Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.MDRNA wins million milestone payment from Amylin
Under terms of the amended agreement, Amylin has committed to advancing the program, resulting in an accelerated $1 million milestone payment to MDRNA. Further, under terms of the
Under terms of the amended agreement, Amylin has committed to advancing the program, resulting in an accelerated $1 million milestone payment to MDRNA. Further, under terms of the
Ablynx and Boehringer Ingelheim have previously entered into an agreement to collaborate on the discovery, development and commercialization of up to 10 different Nanobody therapeutics across a range
This study is designed to evaluate the safety, tolerability, and ocular pharmacokinetics of topically applied ESBA105 in patients, as well as assess the preventive activity on ocular inflammation
This agreement calls for proton range compensators and apertures to be manufactured in Sanford, Florida and shipped to the facility in Oklahoma within 24-72 hours. With the addition
Dr La was most recently vice president of pharmacogenetics experimental project coordination and analysis, at GlaxoSmithKline. Dr Lai has earned a PhD in pharmacology and microbiology from Columbia
The team will seek an investigational new drug (IND) permission from the FDA to utilize Champions Biotechnology’s Biomerk Tumorgraft technology to develop personalized vaccines for cancer patients. Under
The trial – a randomized, double-blind, placebo-controlled, parallel group, dose-escalation study of intravenously administered ACHN-490 – is supported by the GBP4.1 million seeding drug discovery award received from
Tindamax is an oral antimicrobial drug approved by the FDA for the treatment of both trichomoniasis and bacterial vaginosis (BV). BioComp Pharma will begin shipping the generic version
EpiCept, a specialty pharmaceutical company, has announced that the FDA indicated that the company has the necessary pivotal data to file a new drug application for Ceplene in
In his role as vice president of preclinical development, Mr Tabrizi will guide the company’s therapeutic antibody discovery programs into clinical development. He will also lead compound assessment,